Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 968487813 | 9684878 | 13 | F | 2013 | 20160818 | 20131112 | 20160822 | EXP | CA-ROCHE-1183959 | ROCHE | 48.54 | YR | F | Y | 116.00000 | KG | 20160822 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 968487813 | 9684878 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | B20151,B20192,B2034 | 125276 | 800 | MG | SOLUTION FOR INFUSION | ||||||
| 968487813 | 9684878 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | WEEKLY | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 968487813 | 9684878 | 3 | SS | NAPROSYN | NAPROXEN | 1 | Unknown | U | 17581 | ||||||||||
| 968487813 | 9684878 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | U | 0 | 20 | MG | /wk | |||||||
| 968487813 | 9684878 | 5 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | ||||||||||||
| 968487813 | 9684878 | 6 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 968487813 | 9684878 | 7 | C | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
| 968487813 | 9684878 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 968487813 | 9684878 | 9 | C | GLUCOSAMINE SULFATE | GLUCOSAMINE SULFATE | 1 | 0 | ||||||||||||
| 968487813 | 9684878 | 10 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 968487813 | 9684878 | 11 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 968487813 | 9684878 | 1 | Rheumatoid arthritis |
| 968487813 | 9684878 | 2 | Rheumatoid arthritis |
| 968487813 | 9684878 | 3 | Product used for unknown indication |
| 968487813 | 9684878 | 4 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 968487813 | 9684878 | OT |
| 968487813 | 9684878 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 968487813 | 9684878 | Arthralgia | |
| 968487813 | 9684878 | Blood bilirubin increased | |
| 968487813 | 9684878 | Drug ineffective | |
| 968487813 | 9684878 | Dyskinesia | |
| 968487813 | 9684878 | Fatigue | |
| 968487813 | 9684878 | Feeling cold | |
| 968487813 | 9684878 | Fibromyalgia | |
| 968487813 | 9684878 | Intervertebral disc protrusion | |
| 968487813 | 9684878 | Liver function test increased | |
| 968487813 | 9684878 | Musculoskeletal stiffness | |
| 968487813 | 9684878 | Nephrolithiasis | |
| 968487813 | 9684878 | Otitis media | |
| 968487813 | 9684878 | Pain | |
| 968487813 | 9684878 | Pustular psoriasis | |
| 968487813 | 9684878 | Restless legs syndrome | |
| 968487813 | 9684878 | Rheumatoid arthritis | |
| 968487813 | 9684878 | Swelling | |
| 968487813 | 9684878 | Upper respiratory tract infection | |
| 968487813 | 9684878 | Urinary tract infection | |
| 968487813 | 9684878 | Weight abnormal | |
| 968487813 | 9684878 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 968487813 | 9684878 | 1 | 20121214 | 20140729 | 0 | |
| 968487813 | 9684878 | 2 | 20140826 | 0 | ||
| 968487813 | 9684878 | 4 | 201402 | 0 |